These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8738678)

  • 21. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
    Jones RN
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S13-24. PubMed ID: 16323115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vancomycin and teicoplanin: differential aspects].
    Cobo J
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):600-10. PubMed ID: 8808477
    [No Abstract]   [Full Text] [Related]  

  • 23. Managing infections of the vascular access.
    Sprague A
    Nephrol News Issues; 2008 Jun; 22(7):38-40. PubMed ID: 18604917
    [No Abstract]   [Full Text] [Related]  

  • 24. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients.
    Koc Y; Snydman DR; Schenkein DS; Miller KB
    Bone Marrow Transplant; 1998 Jul; 22(2):207-9. PubMed ID: 9707033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of vancomycin in the treatment paradigm.
    Stevens DL
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
    Munoz-Price LS; Lolans K; Quinn JP
    Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
    [No Abstract]   [Full Text] [Related]  

  • 29. Case of vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunt that was treated with quinupristin/dalfopristin after bacteremia persisted with alatrofloxacin therapy.
    Zaman MM; Recco R; Tejwani U; Scuto TJ; Ahmed S; Hypolite A; Jayaraman G
    Clin Infect Dis; 1999 Oct; 29(4):954-5. PubMed ID: 10589932
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy.
    Working P
    Heart; 1998 Feb; 79(2):207-10. PubMed ID: 9538323
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.
    Rijnders BJ; Van Wijngaerden E; Vandecasteele SJ; Stas M; Peetermans WE
    J Antimicrob Chemother; 2005 Jan; 55(1):90-4. PubMed ID: 15574481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocarditis caused by Gemella morbillorum resistant to beta-lactams and aminoglycosides.
    Kofteridis DP; Anastasopoulos T; Panagiotakis S; Kontopodis E; Samonis G
    Scand J Infect Dis; 2006; 38(11-12):1125-7. PubMed ID: 17148095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 34. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [First case of infection due to vancomycin resistant Enterococcus faecalis in New Caledonia].
    Garin B; Barny S; Lechevallier S; Agathe-Nerine J
    Med Mal Infect; 2006 May; 36(5):297-8. PubMed ID: 16631333
    [No Abstract]   [Full Text] [Related]  

  • 38. Vancomycin peak serum concentration monitoring.
    Tam VH; Moore GE; Triller DM; Briceland LL
    J Intraven Nurs; 1999; 22(6):336-42. PubMed ID: 10865602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leuconostoc bacteremia in a healthy infant.
    Casanova-Román M; Rios J; Sánchez-Porto A; Gomar JL; Casanova-Bellido M
    Minerva Pediatr; 2003 Feb; 55(1):83-6. PubMed ID: 12660631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review.
    Florescu D; Hill L; Sudan D; Iwen PC
    Pediatr Infect Dis J; 2008 Nov; 27(11):1013-9. PubMed ID: 18833028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.